New Mechanisms, New Agents in Antiplatelet Therapy
2011-07-23 - English
to be announced!

New mechanisms, new agents in
antiplatelet therapy

P2Y12, one of two adenosine diphosphate platelet receptors, is the target of the thienopyridines
ticlopidine and clopidogrel. Although both are efficacious antithrombotic agents, the less toxic
clopidogrel has...(more)

Biomarkers in ACS: Prognostic Indicators or Meaningful Endpoints?
2011-07-23 - English
to be announced!

Biomarkers in ACS: prognostic indicators
or meaningful endpoints?

Risk stratification in acute coronary syndromes (ACS) is assuming increasing importance as
more effective therapies emerge for reducing risk. Prognosis varies widely in ACS patients as a
result of both...(more)

Genetic influences on platelet function: Recent insights
2011-07-23 - English
to be announced!

Genetic influences on platelet function:
recent insights

Single nucleotide polymorphisms of the gene encoding CYP450 2C19 are independently
associated with reduced generation of the active metabolite of clopidogrel, reduced inhibition of
adenosine diphosphate-induced...(more)

Biological Functions and Therapeutic Potential of Vascular Endothelial Growth Factors
2011-07-25 - English

The role of glycans and lectins in platelet clearance
2011-07-25 - English

Novel regulators of thrombus growth and stability
2011-07-25 - English

Clearance of misfolded proteins by PA system and contact system
2011-07-25 - English

Crosstalk between hemostasis and inflammation
2011-07-25 - English

Recombinant thrombomodulin: As a therapeutic regulator in coagulation and inflammation
2011-07-25 - English

Challenge to novel bioactive peptides
2011-07-26 - English

Advances in our understanding of the molecular basis of inherited disorders of platelet function
2011-07-26 - English

- The molecular basis of inherited disorders of platelet function

- The mechanisms of platelet adhesion, secretion and aggregation

- The pathophysiology of the alphaIIbbeta3 integrin

- The fine tuning of platelet production

- The application of new generation molecular biology approaches to the
screening of are diseases

HIT paradigms and paradoxes
2011-07-26 - English

von Willebrand factor: The complex molecular genetics of a multidomain and multifunctional protein
2011-07-26 - English

The domain architecture of VWF and activation by elongational flow
2011-07-26 - English

Tissue factor and cell signaling in cancer progression and thrombosis
2011-07-26 - English

Historical perspective and future direction in thrombolysis research
2011-07-27 - English

Atherothrombosis and the role of antiplatelet therapy
2011-07-27 - English

Improving care with oral antiplatelet therapy:
lessons from recent large outcomes trials

The treatment of acute coronary syndromes (ACS) involves dual antiplatelet therapy,
usually with a combination of aspirin and clopidogrel. However, clopidogrel is a pro-drug
and...(more)

Platelet adhesion and activation in arterial thrombosis
2011-07-27 - English

Discovery of novel platelet aggregation and platelet function loci through genome.wide studies
2011-07-27 - English

Historical perspective and future direction in coagulation research
2011-07-27 - English

Dynamic regulation of vascular cell adhesion
2011-07-28 - English

Managing acquired hemophilia
2011-07-28 - English

Discovery of the cardiovascular system: From Galen to William Harvey
2011-07-28 - English

Natural history of Upshaw.Schulman syndrome based on ADAMTS13 gene analysis
2011-07-28 - English

Welcome and introduction
2011-09-08 - English
to be announced!

- discuss global epidemiology of atherothrombosis
- discuss the role of antiplatelet therapy in secondary and primary prevention of atherothrombosis